BRISTOL-MYERS SQUIBB COMPANY Inventory, Finished Goods, Net of Reserves
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Inventory, Finished Goods, Net of Reserves of $993.00 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-07-30
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $993.00M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $894.00M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $900.00M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $1.06B.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $993.00M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $894.00M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $900.00M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $1.06B 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $1.16B 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $1.26B 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $1.26B 10-K · filed 2026-02-11 | |
| 2024-09-30 | $1.08B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $862.00M 10-Q · filed 2024-07-26 | |
| 2024-03-31 | $885.00M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $663.00M 10-K · filed 2025-02-12 | |
| 2023-09-30 | $533.00M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $594.00M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $594.00M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $509.00M 10-K · filed 2024-02-13 | |
| 2022-09-30 | $357.00M 10-Q · filed 2022-10-26 | |
| 2022-06-30 | $469.00M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $449.00M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $543.00M 10-K · filed 2023-02-14 | |
| 2021-09-30 | $849.00M 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $891.00M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $806.00M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $932.00M 10-K · filed 2022-02-09 | |
| 2020-09-30 | $822.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.52B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.28B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.23B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $306.00M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $460.00M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $448.00M 10-Q · filed 2019-04-25 | |
| 2018-12-31 | $356.00M 10-K · filed 2020-02-24 | $396.00M 10-K · filed 2019-02-25 |
| 2017-12-31 | $384.00M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |